Researchers across the world are using QIAGEN Digital Insights solutions to accelerate their work in a variety of applications
Powerful insights help innovate, integrate and translate scientific results into impactful discoveries. Many noteworthy papers cite QIAGEN Digital Insights solutions and demonstrate how our tools help drive research insights and discoveries. These papers use QIAGEN Ingenuity Pathway Analysis (IPA), QIAGEN CLC and/or QIAGEN OmicSoft to help drive success. The QIAGEN Digital Insights portfolio encompasses a comprehensive, easy-to-use toolbox that ensures continuity in NGS workflow. Here, we have curated a selection of just a few recent papers to offer a sense of the diversity of the research for which QIAGEN Digital Insights solutions makes a difference.
First Author: Athina Giannoudis
In honor of World Cancer Day, discover how Dr. Giannoudis and colleagues at the University of Liverpool investigate differentially expressed miRNAs in breast cancer that has metastasized to the brain. See how the team uses QIAGEN IPA to identify miRNA biomarkers that may be predictive of survival. Read the paper here.
CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities
First Author: Tomasz Ahrends
Read about the exciting research by T. Ahrends and colleagues at Netherlands Cancer Institute who perform a whole genome analysis to study how CD4+ T cells help generate CD8+ cytotoxic T cells. In order to identify the function and subcellular localization of the genes, the team uses QIAGEN IPA to determine which genes are differentially expressed when support from CD4+ T cells is available. Read the entire paper here.
Mediator MED23 regulates inflammatory responses and liver fibrosis
First Author: Zhichao Wang
Dive into the details of new and noteworthy research by Z. Wang and colleagues at Fudan University who study the role of MED23 in the development of liver fibrosis. Read about how the team uses QIAGEN IPA to tease out the involvement of MED23 by predicting upstream regulators of upregulated genes in a MED23 knockout mouse model, and potential targets for therapeutic intervention in liver fibrosis. Delve into the team’s research here.
Changes in DNA methylation from pre- to post-adolescence are associated with pubertal exposures
First Author: Luhang Han
To recognize Reproductive Health Day, read fascinating research by L. Han and colleagues at the University of Memphis, who perform a longitudinal study to identify epigenetic changes from pre- to post-adolescence. See how the team uses QIAGEN IPA to investigate pathways affected by the DNA methylation changes associated with puberty and environmental factors. Explore the paper here.
Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia
First author: Seth E. Karol
In honor of International Childhood Cancer Day (February 14, 2020), we are highlighting this previous paper from researchers at St. Jude. Seth Karol and colleagues performed a genome-wide association study with over 2000 children and use QIAGEN IPA to identify the genetic causes of osteonecrosis that occur during glucocorticoid therapy given to children with acute lymphoblastic leukemia. Read the full paper here.
A novel mouse model of enteric Vibrio parahaemolyticus infection reveals that the type III secretion system 2 effector VOPC plays a key role in tissue invasion and gastroenteritis
First author: Hyungiun Yang
Dig into this interesting study by H. Yang and colleagues from the University of British Columbia, which reveals how V. parahaemolyticus, a bacteria commonly found in contaminated seafood, causes gastroenteritis in humans. Read how the team uses QIAGEN IPA to study the T3SS2 secretion system to show that its effectors are necessary to cause gut infection. Access the full article here.
Loss of amyloid precursor protein exacerbates early inflammation in Niemann-Pick disease type C
First author: Samuel D. Shin
For Rare Disease Day, February 28, 2020, we are highlighting research by Samuel Shin and colleagues from Loma Linda University who are studying Niemann-Pick disease type C, a lethal neurodegenerative condition, affecting one in 100,000 thousand children. Find out how the team uses QIAGEN IPA to reveal how the loss of amyloid precursor protein contributes to the neuroinflammation observed in this disease. Access the paper here.
First author: Alexandra E. Butler
Dr. A. Butler and colleagues from Hamad Bin Khalifa University (HBKU) look at the differences in miRNA expression in follicular fluid of women with polycystic ovary syndrome (PCOS). In this recent paper, the team used QIAGEN IPA to extensively look at the differential expression of these small non-coding RNAs and identified 12 miRNAs that are involved in reproductive pathways, 12 related to inflammatory disease and 6 implicated in benign pelvic disease.
First author: Claudia Rossi
Researchers use QIAGEN IPA to analyze the tears of glaucoma patients in this multi-‘omics study to understand primary open-angle glaucoma (PAOG). In the research paper, the team performed metabolomics and proteomics analyses to identify key differences that may result in new screening options for this disease, which is the leading cause of irreversible blindness.
First author: Wenyu Zhou
Zhou and colleagues from Stanford University perform a multi-‘omics study looking into the connection between host-microbiome interaction and the predisposition to type-2 diabetes. In this Nature article, read how the team uses QIAGEN IPA to search for enriched pathways to understand how changes during respiratory viral infections can lead to the development of diabetes.
First author: Ayush Giri
Significant research by Dr. A. Giri and colleagues from Vanderbilt University who are involved in the investigation of over 750,000 individuals for genetic variants that affect blood pressure. Discover how the team uses QIAGEN IPA to identify enriched pathways involving the 840 genes predicted to be associated with blood pressure regulation.
First author: Eva Moran-Salvador
Discover the research by Dr. E. Moran-Salvador and colleagues from Newcastle University who study the role of MECP2 expressed by hepatic stellate cells (HSCs) in liver fibrosis. See how the team uses QIAGEN IPA to identify enriched pathways where MECP2 is involved, and how the deletion of MECP2 leads to reduced fibrosis in mice.
First author: Fok-Moon Lum
Dr. F Lum and colleagues from Agency for Science, Technology and Research, Singapore look at placental development during pregnancy after a Zika virus infection. In this paper, see how the team uses QIAGEN IPA to identify eIF2 as the major canonical pathway involved in the differential gene expression pattern when compared to healthy controls.
First author: Satoshi Muraoka
Dr. S. Muraoka and colleagues look at the proteomic profile of cerebrospinal fluid samples from former NFL players to understand the biology of chronic traumatic encephalopathy, a condition that affects individuals with a history of repetitive mild traumatic brain injury. In this research paper, the team use QIAGEN IPA to look at upstream regulators, pathways and functional networks of the differentially expressed proteins to identify a plausible biomarker.
First author: Lei Tan
Crucial research by Dr. L. Tan and colleagues from Weill Cornell Medical College strives to reveal the outcomes of a Zika virus infection during the pre- and peri-implantation stage of pregnancy. Learn how the team used QIAGEN IPA to identify two key gene networks that are strongly affected by the virus.
Multi-omics analysis identifies mitochondrial pathways associated with anxiety-related behavior
First author: Zuzanna Misiewicz
Check out this interesting paper by Dr. Z. Misiewicz and colleagues from University of Helsinki who use a multi-‘omics approach to understand the molecular mechanisms behind anxiety and stress disorders. Discover how the team use QIAGEN IPA to identify certain mitochondrial genes in blood cells related to these debilitating disorders.
First author: Nanna Fyhrquist
Interesting research by Dr. N. Fyhrquist and colleagues from the Karolinska Institute who study the interplay between the skin microbiome and skin diseases such as dermatitis and psoriasis. The team use QIAGEN IPA to identify key regulators and pathway activation in host cells to identify transcriptomic signatures for skin barrier function, tryptophan metabolism and immune activation as a basis for plausible biomarkers and targeted therapies.
Zinc chelation specifically inhibits early stages of Dengue virus replication by activation of NF-κB and induction of antiviral response in epithelial cells
First author: Meenakashi Kar
Dr. M. Kar and colleagues from Translational Health Science and Technology Institute in Faridabad, India (THSTI) perform cutting-edge immunology research using QIAGEN IPAs to understand how zinc chelation can inhibit early stages of Dengue virus by activating NFkB to induce an antiviral response in epithelial cells.
First Author: Yuanyuan Zhang
Researchers at Wageningen University use QIAGEN CLC Genomics Workbench to study the leaf transcriptomes and metabolomes of Capsicum peppers to identify how they fight spider mite infections. Read the full story here.
Hippocampal clock regulates memory retrieval via Dopamine and PKA-induced GluA1 phosphorylation
First author: Shunsuke Hasegawa
Intriguing research by S. Hasegawa and colleagues at Tokyo University who investigate the role of the circadian clock in memory retrieval. See how the team uses both QIAGEN CLC Genomics Workbench and QIAGEN IPA to understand how circadian-dependent transcription factor BMAL1 contributes to loss of memory retrieval in the late afternoon. Read the details here.
Rousette bat dendritic cells overcome Marburg virus-mediated antiviral responses by upregulation of interferon-related genes while downregulating proinflammatory disease mediators
First author: Joseph Prescott
Fascinating research by J. Prescott and colleagues from the US Centers for Disease Control and Prevention (CDC) which focuses on how the immune system of the rousette bat coexists with the Marburg virus. See how the team uses QIAGEN’s CLC Genomics Workbench and QIAGEN IPA to understand how bat dendritic cells downregulate immune maturation while upregulating pathogen-sensing pathways during a viral infection. Explore the topic further here.
Coronary arterial development is regulated by a Dll4-Jag1-EphrinB2 signaling cascade
First author: Stanislao Igor Travisano
In honor of American Heart Month, we are highlighting research by S. Travisano and team from Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Spain, who investigate the role of the Notch signaling pathway in coronary arterial development. Learn how they use both QIAGEN CLC Genomics Workbench and QIAGEN IPA to show the importance of the Dll4-Jag1-EphrinB2 signaling cascade in coronary angiogenesis. Get the details by accessing the full paper here.
First author: Sridhar Selvaraj
Exciting research from the University of Minnesota where Selvaraj et al. examine a combination of small molecules can help with the development of pluripotent stem cells into mature myotubules. Read how the team uses QIAGEN CLC Genomics Workbench and QIAGEN IPA to understand how these small molecules help with stem cell maturation.
First author: Reem Saleh
In this paper, read how researchers at HBKU use QIAGEN Genomics Workbench and QIAGEN IPA to understand how atezolizumab targets PD-L1 and helps in the treatment of triple-negative breast cancer, the most aggressive type of breast cancer.
First author: Shu-Ting You
Delve into this interesting research paper by You and colleagues from Academia Sinica in Taiwan where they study the role of methyltransferase Hmt1 in regulating noise buffering. See how the team uses QIAGEN CLC Genomics Workbench to identify Hmt-1 as a master regulator that adjusts protein noise levels in response to stressful environments.
Micro RNA transcriptome profile in canine oral melanoma
First author: Md. Mahfuzur Rahman
In this recent paper, researchers use QIAGEN CLC Genomics Workbench to understand the miRNA transcriptome profile in canine oral melanoma and how it plays a role in cancer pathogenesis. The team links their observations to three oncogenic miRNAs targets (miR-450b, 301a and 223) from a human study that were also down-regulated in canine oral melanoma and had a significant negative correlation with their respective miRNAs.
First author: Xiucheng Cui
Fascinating research out of the Ottawa Research and Development Centre where a team has developed a method to delete large segments of the genome using the CRISPR/Cas9 technique. See how they apply QIAGEN CLC Genomics Workbench to help them use an optimized Cas-9 plant codon to edit hexaploidic wheat genomes.
Genome sequence of a novel Enterococcus faecalis sequence type 922 strain isolated from a door handle in the intensive care unit of a district hospital in Durban, South Africa
First author: Christiana Shobo
December 1–7 is National Handwashing Awareness Week. Washing your hands is one of the easiest ways to prevent overuse of antibiotics and fight antimicrobial resistance. This work by Dr. C. Shobo and colleagues from the University of KwaZulu-Natal demonstrate this by using QIAGEN CLC Genomics Workbench to investigate the resistome of a novel Enterococcus faecalis found on the door handle of an intensive care unit (ICU) in South Africa. Check it out!
First author: Jiajia Xu
Interesting research by Dr. J Xu and colleagues from Johns Hopkins University show how extracellular vesicles (EVs) derived from human perivascular stem cells (PSCs) are able to repair bone by stimulating osteoblasts just like PSCs. Discover how the team use QIAGEN CLC Genomics Server and Workbench to understand the transcriptomics of the EVs.
First author: Valentina Valenzuela-Muñoz
Research by V. Valenzuela-Muñoz and colleagues from University of Concepción use QIAGEN CLC Genomics Workbench to discover the role of long non-coding RNAs (lncRNAs) in the infection of zebrafish with spring viraemia of carp virus.
First author: Maria Harmati
M. Harmati and colleagues from the University of Szeged use both QIAGEN CLC Genomics Workbench and QIAGEN Ingenuity Pathway Analysis to investigate how extracellular vesicles from melanoma cells convey adaptive stress responses. In their paper, they leverage these insights to illustrate how to predict different stress responses which could influence efficacy of treatments based on therapy-induced host responses.
QIAGEN OmicSoft Array Suite and Lands
First Author: David Michalovich
Discover this interesting and relevant research by a team at GSK who leverage QIAGEN OmicSoft Array Studio to investigate the connection between obesity and asthma severity. They find the gut microbiome plays a significant role in these conditions. Check out the full paper here.
Reduced TRPM8 expression underpins reduced migraine risk and attenuated cold pain sensation in humans
First author: Narender R. Gavva
Researchers from Amgen use QIAGEN OmicSoft Array Studio in this study to understand how a specific allele in TRPM8 can act as a cold sensor to reduce migraine risk in humans located in colder climates.
First author: Karen Dubois-Camacho
In this recent paper, researchers at the Universidad de Chile use QIAGEN OmicSoft Array Studio to study the role of miRNAs in regulating pro-inflammatory mediators such as IL-33 in ulcerative colitis, a form of inflammatory bowel disease.
First author: Alexandra Bocharnikov
Researchers from Harvard, Merck, Johns Hopkins and several other prominent institutions collaborate in this research paper and use QIAGEN OmicSoft Array Studio and QIAGEN IPA to understand how T peripheral helper cells contribute to B cell dysfunction in lupus.
First author: Carl L Manthey
In this recent paper, read how researchers from Janssen Research and Development use QIAGEN OmicSoft Array Studio and QIAGEN IPA to demonstrate the involvement of macrophages in Crohn’s disease and how inhibition of the CSF-1 pathway helped in attenuating the disease in mice.
First author: Haiyan Xu
Dr. H. Xu and colleagues from Merck study the ability of bone marrow cells from acute myeloid leukaemia (AML) patients to resist cancer treatment in a 3D cell culture system. Read how the team use QIAGEN OmicSoft Studio to identify unique gene expression signatures and novel genetic mutations associated with sensitivity to Ara‐C treatment in proliferating AML cells. These unique signatures could potentially be used as predictive biomarkers to determine optimal treatment regimens.
Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo
First author: Kathleen M. McAvoy
Interesting research from Dr. K. McAvoy and colleagues from Biogen and Harvard Medical School who study the genetic contribution of neuronal-specific BIN1 isoforms in late onset Alzheimer’s disease. Learn how the team use QIAGEN OmicSoft Array Studio and QIAGEN Ingenuity Pathway Analysis to look at gene enrichment and activated pathways in BIN1-knockout mice to better understand this disease.
To request information on the QIAGEN Digital Insight Solutions, contact email@example.com.